CAM Group Holding A S boosted its stake in shares of McKesson Corp. (NYSE:MCK) by 2.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,292,475 shares of the company’s stock after buying an additional 33,903 shares during the period. McKesson Corp. makes up approximately 4.6% of CAM Group Holding A S’s holdings, making the stock its 11th largest position. CAM Group Holding A S owned 0.57% of McKesson Corp. worth $241,241,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently made changes to their positions in the stock. Wellington Management Group LLP increased its stake in shares of McKesson Corp. by 9.3% in the first quarter. Wellington Management Group LLP now owns 11,312,022 shares of the company’s stock valued at $1,778,816,000 after buying an additional 961,630 shares in the last quarter. Geode Capital Management LLC raised its position in McKesson Corp. by 1.6% in the first quarter. Geode Capital Management LLC now owns 1,897,745 shares of the company’s stock valued at $297,829,000 after buying an additional 29,337 shares during the last quarter. Scharf Investments LLC raised its position in McKesson Corp. by 11,803.7% in the first quarter. Scharf Investments LLC now owns 1,190,016 shares of the company’s stock valued at $187,130,000 after buying an additional 1,180,019 shares during the last quarter. Legal & General Group Plc raised its position in McKesson Corp. by 2.8% in the first quarter. Legal & General Group Plc now owns 1,124,131 shares of the company’s stock valued at $176,779,000 after buying an additional 30,231 shares during the last quarter. Finally, Southpoint Capital Advisors LP raised its position in McKesson Corp. by 18.8% in the first quarter. Southpoint Capital Advisors LP now owns 1,069,642 shares of the company’s stock valued at $168,201,000 after buying an additional 169,642 shares during the last quarter. Institutional investors own 84.75% of the company’s stock.

Institutional Ownership by Quarter for McKesson Corp. (NYSE:MCK)

McKesson Corp. (NYSE:MCK) traded up 0.90% on Tuesday, hitting $162.10. 743,683 shares of the company’s stock traded hands. McKesson Corp. has a 12 month low of $148.29 and a 12 month high of $202.20. The stock has a market cap of $36.59 billion, a P/E ratio of 16.83 and a beta of 0.93. The stock has a 50 day moving average price of $170.54 and a 200-day moving average price of $179.56.

McKesson Corp. (NYSE:MCK) last announced its quarterly earnings data on Wednesday, July 27th. The company reported $3.50 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.33 by $0.17. The company earned $49.73 billion during the quarter, compared to the consensus estimate of $50.32 billion. McKesson Corp. had a return on equity of 31.62% and a net margin of 1.15%. The firm’s revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $3.14 EPS. Equities analysts predict that McKesson Corp. will post $13.63 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, October 3rd. Investors of record on Thursday, September 1st were paid a dividend of $0.28 per share. The ex-dividend date of this dividend was Tuesday, August 30th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.69%. McKesson Corp.’s dividend payout ratio (DPR) is presently 11.64%.

Several equities analysts recently weighed in on the stock. Deutsche Bank AG restated a “buy” rating on shares of McKesson Corp. in a research report on Monday, July 18th. Morgan Stanley increased their price target on shares of McKesson Corp. from $199.00 to $211.00 and gave the company an “overweight” rating in a research report on Thursday, July 28th. Citigroup Inc. increased their price target on shares of McKesson Corp. from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Thursday, July 28th. Mizuho increased their price target on shares of McKesson Corp. from $174.00 to $197.00 and gave the company a “neutral” rating in a research report on Thursday, August 11th. Finally, JPMorgan Chase & Co. increased their price target on shares of McKesson Corp. from $210.00 to $221.00 and gave the company an “overweight” rating in a research report on Tuesday, August 9th. One analyst has rated the stock with a sell rating, eight have given a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $201.17.

In related news, Director Wayne A. Budd sold 2,309 shares of the business’s stock in a transaction that occurred on Monday, September 12th. The stock was sold at an average price of $179.70, for a total transaction of $414,927.30. Following the completion of the transaction, the director now directly owns 723 shares in the company, valued at approximately $129,923.10. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Chairman John H. Hammergren sold 100,500 shares of the business’s stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $184.22, for a total value of $18,514,110.00. Following the transaction, the chairman now owns 100,500 shares of the company’s stock, valued at $18,514,110. The disclosure for this sale can be found here. Corporate insiders own 1.15% of the company’s stock.

McKesson Corp. Company Profile

McKesson Corporation (McKesson) is a pharmaceutical distribution services and information technology company. The Company delivers an offering of pharmaceuticals and medical supplies. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The Distribution Solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products around the world and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices.

5 Day Chart for NYSE:MCK

Receive News & Stock Ratings for McKesson Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corp. and related stocks with our FREE daily email newsletter.